S1. CLOZAPINE RECHALLENGE FOLLOWING NEUTROPENIA USING GRANULOCYTE COLONY-STIMULATING FACTOR: A QUEBEC CASE SERIES

BACKGROUND: Clozapine possesses unique efficacy profile in treatment-resistant schizophrenia but is associated with neutropenia and agranulocytosis, in respectively, 3% and 0.7% of exposed patients. Granulocyte colony-stimulating factor (G-CSF) has been used to allow clozapine continuation or rechal...

Descripción completa

Detalles Bibliográficos
Autores principales: Béchard, Laurent, Corbeil, Olivier, Plante, Maude, Thivierge, Marc-André, Lafrenière, Charles-Émile, Roy, Marc-André, Demers, Marie-France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session I
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234194/
http://dx.doi.org/10.1093/schbul/sbaa031.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234194/
http://dx.doi.org/10.1093/schbul/sbaa031.067

Ejemplares similares